4 unchanged sentences
Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
−Removed: Due to the inherent limitations of control systems, not all misstatements may be detected.
+Added: Due to the inherent limitations of control
+Added: systems, not all misstatements may be detected.
These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of a simple error or mistake.
7 unchanged sentences
● Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors;
−Removed: ● Provide reasonable assurances regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material adverse effect on our financial statements.
+Added: ● Provide reasonable assurances regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2021 based on the criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO 2013.
6 unchanged sentences
Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.
−Removed: Attestation Report of the Registered Public Accounting Firm
−Removed: This Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm on our internal controls due to an exemption established by the JOBS Act for “emerging growth companies.”
Changes in Internal Control Over Financial Reporting
−Removed: There were no changes in our internal control over financial reporting that occurred during the fiscal year ended December 31, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
+Added: There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Other Information
Not applicable.
+Added: Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
+Added: Not applicable.
Directors, Executive Officers and Corporate Governance
44 unchanged sentences
and ARE-819/863 Mitten Road, LLC.
+Added: Eighth Amendment to Office Lease, dated as of September 13, 2021, by and between Corvus Pharmaceuticals, Inc.
+Added: and ARE 819/863 Mitten Road, LLC .
+Added: Sublease agreement, dated August 1, 2021, by and between Corvus Pharmaceuticals, Inc.
+Added: and Angel Pharmaceuticals US Inc.
2014 Equity Incentive Plan.
3 unchanged sentences
Form of Stock Option Grant Notice and Stock Option Agreement under the 2014 Equity Incentive Award Plan.
+Added: Incorporated by Reference
+Added: Exhibit Description
Form of Restricted Stock Purchase Right Grant Notice and Restricted Stock Purchase Agreement under the 2014 Equity Incentive Plan.
1 unchanged sentence
Form of Stock Option Grant Notice and Stock Option Agreement under the 2016 Equity Incentive Award Plan.
−Removed: Incorporated by Reference
−Removed: Exhibit Description
Form of Restricted Stock Award Agreement and Restricted Stock Award Grant Notice under the 2016 Equity Incentive Award Plan.
9 unchanged sentences
and William B.
−Removed: Employment Agreement, dated as of November 26, 2014 by and between Corvus Pharmaceuticals, Inc.
−Removed: and Joseph J.
−Removed: Transition and Consulting Agreement, dated as of June 30, 2020 by and between Corvus Pharmaceuticals, Inc.
−Removed: and Joseph J.
−Removed: Offer Letter, dated as of January 7, 2019 by and between Corvus Pharmaceuticals, Inc.
−Removed: and Mehrdad Mobasher.
−Removed: Change in Control and Severance Agreement, dated January 28, 2019, by and between Corvus Pharmaceuticals, Inc.
−Removed: and Mehrdad Mobasher.
Corvus Pharmaceuticals, Inc.
17 unchanged sentences
and Genentech, Inc.
−Removed: Incorporated by Reference
−Removed: Exhibit Description
Amendment No.
3 unchanged sentences
and Monash University.
−Removed: Exchange Agreement, dated November 8, 2019, by and among Corvus Pharmaceuticals, Inc., Biotechnology Value Fund II, L.P.
−Removed: and Biotechnology Value Trading Fund OS, L.P.
+Added: Incorporated by Reference
+Added: Exhibit Description
Framework Agreement, dated as of October 5, 2020, by and between Corvus Hong Kong Limited, Jiaxing Puissance Angel Equity Investment Partnership (Limited Partnership) and AP BIOTECH DEVELOPMENT CORP.
1 unchanged sentence
and Jefferies LLC.
+Added: Open Market Sale Agreement, dated November 1, 2021, by and between Corvus Pharmaceuticals, Inc.
+Added: and Jefferies LLC.
List of subsidiaries
45 unchanged sentences
Grais, M.D., J.D.
−Removed: March 25, 2021
MITCHELL, M.D.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.